FAP is an emerging therapeutic target due to its upregulated expression in tumor stroma and tissue remodeling, including liver fibrosis, lung fibrosis, colorectal cancer, ovarian cancer, prostate cancer, and arthritis.[18–21] Besides, FAP has been associated with cell migration and cell invasiveness. This evidence concerns the gene FAP and ovarian carcinoma.